AZURECELL SA

Regenerating neurons to defeat rejuvenate the brain

AzureCell is an award-winning biotech spin-off from the University of Geneva, advancing next-generation regenerative cell therapies for Parkinson’s disease and other neurodegenerative disorders. By integrating cutting-edge stem cell technologies with proprietary cell and genetic engineering platforms, we’re developing scalable, safe, and effective therapies that address the root cause of neurodegeneration.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
REGISTER
Milestone

17.12.2025

Kickfund CLA

Milestone

09.12.2025

First Business Angel Investment

Milestone

09.07.2025

Venture Kick Stage 3

Milestone

16.05.2025

Top 10 Finalists W.A. de Vigier Awards

Milestone

19.02.2025

Venture Kick Stage 2

Show more...

No Jobs

Videos

Youtube

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (150'000) 2025

Website

AZURECELL SA

Regenerating neurons to defeat rejuvenate the brain

Website:
www.azurecell.co

Headquarter:
Geneva

Foundation Date:
September 2025

Technology:

  • Biotech

Sectors:

  • Biotech
  • Medtech

Support received

  • Support venturekick